Detalhe da pesquisa
1.
EGFR activation limits the response of liver cancer to lenvatinib.
Nature
; 595(7869): 730-734, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290403
2.
Inducing and exploiting vulnerabilities for the treatment of liver cancer.
Nature
; 574(7777): 268-272, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578521
3.
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse.
Cell Rep Med
; 5(3): 101471, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508142
4.
Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity.
PLoS One
; 17(9): e0273182, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36067171
5.
Genetic and compound screens uncover factors modulating cancer cell response to indisulam.
Life Sci Alliance
; 5(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534224
6.
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis.
Nat Cancer
; 3(11): 1284-1299, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36414711
7.
Identification of Autophagy-Related Genes as Targets for Senescence Induction Using a Customizable CRISPR-Based Suicide Switch Screen.
Mol Cancer Res
; 19(10): 1613-1621, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158393
8.
The Cancer SENESCopedia: A delineation of cancer cell senescence.
Cell Rep
; 36(4): 109441, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320349
9.
A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer.
Elife
; 92020 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33016874
10.
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer.
Cell Rep
; 21(3): 773-783, 2017 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045843